Biodexa Pharmaceuticals Plc
(NASDAQ) BDRX
Biodexa Pharmaceuticals Plc Financials at a Glance
Market Cap
$1.40M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.10M
EPS (TTM)
$-20.79
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$0.60
Volume
0
Open
$0.60
Price
$0.60
Volume
0
Open
$0.60
Previous Close
$0.60
Daily Range
$0.60 - $0.60
52-Week Range
$0.60 - $19.30
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$0.60
Volume
0
Open
$0.60
Previous Close
$0.60
Daily Range
$0.60 - $0.60
52-Week Range
$0.60 - $19.30
BDRX News
BDRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biodexa Pharmaceuticals Plc
Industry
Biotechnology
Sector
Health CareEmployees
11
CEO
Stephen Anthony Stamp
Website
www.biodexapharma.comHeadquarters
Cardiff, CF10 4DQ, GB
BDRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-65%
Return on Capital
-73%
Return on Assets
-35%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.40M
Shares Outstanding
2.26M
Volume
0
Short Interest
0.00%
Avg. Volume
254.99K
Financials (TTM)
Gross Profit
$184.86K
Operating Income
$8.27M
EBITDA
$8.08M
Operating Cash Flow
$5.39M
Capital Expenditure
$1.96K
Free Cash Flow
$5.40M
Cash & ST Invst.
$8.52M
Total Debt
$60.89K
Biodexa Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$48.70K
+97.8%
Gross Margin
0.00%
N/A
Market Cap
$1.40M
N/A
Market Cap/Employee
$107.33K
N/A
Employees
13
N/A
Net Income
$2.56M
+27.0%
EBITDA
$4.68M
-104.5%
Quarterly Fundamentals
Net Cash
$8.46M
+53.6%
Accounts Receivable
$221.61K
-68.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$60.89K
-64.0%
Return on Assets
-35.09%
N/A
Return on Invested Capital
-72.66%
N/A
Free Cash Flow
$2.33M
+21.6%
Operating Cash Flow
$2.33M
+21.0%